Shanghai Serum Bio-Technology Hits Day High with 7.61% Surge

Shanghai Serum Bio-Technology Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.61% on June 17, 2026. The stock reached an intraday high of CNY 49.27, reflecting strong activity in the market. Over the past week, the company has shown impressive growth, with a 23.94% increase, significantly outperforming the China Shanghai Composite, which rose by only 2.88% during the same period. In terms of longer-term performance, Shanghai Serum Bio-Technology has demonstrated remarkable resilience, with a 143.02% increase over the past year, compared to the 21.28% rise in the broader market index. Year-to-date, the stock has surged by 119.02%, further highlighting its strong market position. Despite these positive performance indicators, the company faces challenges in management efficiency, as evidenced by a low Return on Capital Employed (ROCE) of 16.43%. Additionally, the company's net sales growth has been modest at an annual rate of 1.64% over the last five years. Nevertheless, the stock's recent performance underscores its notable activity in the pharmaceuticals and biotechnology sector.